Concepedia

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII

Joseph E. Addiego, Carol K. Kasper, C F Abildgaard, M W Hilgartner, Jeanne M. Lusher, Bertil Glader, Louis M. Aledort

The Lancet · 1993 · 166 citations · 9 references

DOI

Concepts

References

9

Characterization of the human factor VIII gene

Jane Gitschier, William I. Wood, Therese M. Goralka et al. · Nature · 1984 · 995 citations

, , +9

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

S. Ehrenforth, W. Kreuz, R. Linde et al. · The Lancet · 1992 · 608 citations

, , +11

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

Jeanne M. Lusher, Steven Arkin, Charles F. Abildgaard et al. · New England Journal of Medicine · 1993 · 494 citations · Full text

, , +14

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

Richard S. Schwartz, Charles F. Abildgaard, Louis M. Aledort et al. · New England Journal of Medicine · 1990 · 266 citations

, , +12

Use of Recombinant Antihemophilic Factor in the Treatment of Two Patients with Classic Hemophilia

Gilbert White, Campbell W. McMillan, Henry S. Kingdon et al. · New England Journal of Medicine · 1989 · 162 citations

, , +9